Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-47

So reading the announcement, I am glad that management of I.M.U. have taken the safe option, but it being the slow option at the same time.

So we know first patient dosed yesterday Monday 30th November and I am hoping that the next 2 patient's are recruited before Christmas.

That will leave us with 30 day's result's, occurring in late January 2021, at earliest.

Once the Cohort Review Committee (CRC) is pleased with the out come of the first 3 patient's, then full steam ahead, with the next lot 3 patient's.

While I can see the enthusiasm of share holder's, one must put a lid on it, has I.M.U. have a very long road ahead, with the up's and also the down.

What I am hoping, that the patient's involved, in this trial, do make a full recovery or at least a 50% recovery, as we must remember, these are very sick patient's and some are starring at heaven's door.

Patience is the key with Bio Stock's.

IMHO.

Regards

Rossi70